Multiple Sclerosis | News | Blogs | Updates | 2023
Women Health | Menopause News | iPharmaCenter
Meningococcal infection | iPharmaCenter
Top pharmaceutical companies by revenues in 2023 | Big Pharma | iPharmaCenter
China Drug Approvals | 2022 | NMPA Drug Approvals | Pharma | Healthcare | China | iPharmaCenter
Deals and Acquisitions | 2023 | Pharma | News | Healthcare | iPharmaCenter
Pharmaceutical Companies Deals and acquisitions | Sanofi | Amgen | Pfizer | 2022 | iPharmaCenter
HAS ASSESSMENT OUTCOMES | FRANCE PHARMA NEWS | médicament nouvelles | 2023 | iPharmaCenter
How is AbbVie bracing for the impact of Humira’s biosimilars? | iPharmaCenter
TOP PHARMACEUTICAL COMPANIES BY REVENUES IN 2022
2022 FDA Drug Approvals | US Pharma News | iPharmaCenter
Top-selling cancer drugs | 2022 | 2023 | Best cancer products | iPharmaCenter
Top 5 drug launches in 2023 that has potential to be blockbusters | iPharmaCenter
Expected best selling drugs of 2023
Access to Medicines | 2021 | 2022 | News | iPharmaCenter | GSK tops list
Multiple Myeloma | News | Blogs | FDA and EMA approvals | Updates on clinical guidelines
Merck and Moderna agreed to develop and commercialize a cancer vaccine | iPharmaCenter
Sanofi gave a statement on the U.S. Zantac litigation | iPharmaCenter
AbbVie's JAK inhibitor, Rinvoq, was approved for UC and nr-axSpA in Europe | iPharmaCenter
Top 20 healthcare companies | iPharmaCenter | Top healthcare companies by revenues
Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter
Expected best selling pharmaceuticals/drugs of 2022
Health Canada Drug Approvals | Healthcare and Pharmaceutical News of Canada | News | Blogs | Canada
Top pharmaceutical companies by revenues in 2021 | Top 10 pharma companies | iPharmaCenter
Australia Drug Approvals | Drugs approved by TGA
Collaborations for drug development in Pharma and Healthcare |
COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine
COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers
Top 20 pharmaceutical companies by revenues in 2020
FDA gave the nod to Pfizer's Paxlovid | Pfizer to supply 2.5 million doses of Paxlovid to the UK
~$10 bn acquisition paying off for Novartis as FDA approved Novartis' Leqvio
Myasthenia Gravis News | FDA and EMA approvals |
Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News
China released the 2022 NDRL list, Chinese pharma benefited from the list
PBAC News Updates
European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19
American College of Rheumatology (ACR) Convergence all-virtual annual meeting Updates
Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief
WHO granted EUL to Covaxin; acclaims easy storage requirement
FDA approved Novartis Scembli for chronic myeloid leukemia
Biogen's Aduhelm received FDA approval for Alzheimer's disease; ICER criticized approval